Creative Medical Technology Holdings (CELZ) Gross Profit (2017 - 2025)

Creative Medical Technology Holdings (CELZ) has reported Gross Profit for 9 consecutive years, with $2006.0 the latest figure, recorded in Q4 2025.

• On a quarterly basis, Gross Profit rose 11.44% year-over-year to $2006.0 in Q4 2025; TTM through Jun 2026 was $2006.0, a 44.28% decrease from a year earlier, with the FY2025 full-year figure at $3806.0, down 42.33% from the prior year.
• Gross Profit was $2006.0 for Q4 2025 at Creative Medical Technology Holdings, up from $1800.0 in the prior quarter.
• Over five years, Gross Profit peaked at $39000.0 in Q3 2022 and troughed at $1800.0 in Q4 2023.
• A 5-year average of $9643.3 and a median of $5150.0 in 2021 frame the typical range for Gross Profit.
• Across the five-year window, Gross Profit soared 550.0% in 2022 and slumped 90.77% in 2023, its largest moves.
• Over 5 years, Gross Profit stood at $28305.0 in 2021, then plunged by 54.43% to $12900.0 in 2022, then plunged by 86.05% to $1800.0 in 2023, then changed by 0.0% to $1800.0 in 2024, then grew by 11.44% to $2006.0 in 2025.
• The last three Gross Profit figures came in at $2006.0 (Q4 2025), $1800.0 (Q1 2025), and $1800.0 (Q4 2024), per Business Quant data.